PARG1 Produits
(rho GTPase Activating Protein 29 (ARHGAP29))
Catégories
GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. Has strong activity toward RHOA, and weaker activity toward RAC1 and CDC42. May act as a specific effector of RAP2A to regulate Rho (By similarity). In concert with RASIP1, suppresses RhoA signaling and dampens ROCK and MYH9 activities in endothelial cells and plays an essential role in blood vessel tubulogenesis (By similarity).
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories PARG1 en vedette
PARG1 Anticorps
High quality antibodies with extensive validation data.
PARG1 Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
PARG1 recommandé Anticorps
Produit
Reactivity
Application
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Application
WB, ELISA, IF (cc), IF (p), IHC (fro), IHC (p)
Validations
- (1)
N° du produit
ABIN762401
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human
Application
WB, ELISA
Validations
- (1)
N° du produit
ABIN564060
Quantité
50 μL
Fiche technique
Fiche technique
Reactivity
Human
Application
WB
Validations
- (1)
N° du produit
ABIN522867
Quantité
50 μL
Fiche technique
Fiche technique
PARG1 recommandé Protéines
Produit
Reactivity
Source
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Source
Wheat germ
Validations
- (1)
N° du produit
ABIN1345511
Quantité
10 μg
Fiche technique
Fiche technique
Reactivity
Mouse
Source
Escherichia coli (E. coli)
Validations
N° du produit
ABIN7423972
Quantité
100 μg
Fiche technique
Fiche technique
Reactivity
Human
Source
Tobacco (Nicotiana tabacum)
Validations
N° du produit
ABIN3095015
Quantité
1 mg
Fiche technique
Fiche technique
Dernières publications sur nos produits PARG1
: "MicroRNA-1291 promotes endometrial fibrosis by regulating the ArhGAP29-RhoA/ROCK1 signaling pathway in a murine model." dans: Molecular medicine reports, Vol. 16, Issue 4, pp. 4501-4510, (2018) (PubMed).: "ARHGAP29 Mutation Is Associated with Abnormal Oral Epithelial Adhesions." dans: Journal of dental research, Vol. 96, Issue 11, pp. 1298-1305, (2017) (PubMed).
: "Rap1 Spatially Controls ArhGAP29 To Inhibit Rho Signaling during Endothelial Barrier Regulation." dans: Molecular and cellular biology, Vol. 35, Issue 14, pp. 2495-502, (2015) (PubMed).
: "Interferon regulatory factor 6 regulates keratinocyte migration." dans: Journal of cell science, Vol. 127, Issue Pt 13, pp. 2840-8, (2014) (PubMed).
: "Rasip1 mediates Rap1 regulation of Rho in endothelial barrier function through ArhGAP29." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Issue 28, pp. 11427-32, (2013) (PubMed).
: "Expression and mutation analyses implicate ARHGAP29 as the etiologic gene for the cleft lip with or without cleft palate locus identified by genome-wide association on chromosome 1p22." dans: Birth defects research. Part A, Clinical and molecular teratology, Vol. 94, Issue 11, pp. 934-42, (2012) (PubMed).
Synonymes et noms alternatifs relatifs à PARG1
Rho GTPase activating protein 29 (ARHGAP29), Rho GTPase activating protein 29b (arhgap29b), Rho GTPase activating protein 29 S homeolog (arhgap29.S), Rho GTPase activating protein 29 (arhgap29), Rho GTPase activating protein 29 (Arhgap29), 6720461J18Rik, A830014I19, arhgap29, ARHGAP29, AU040217, B130017I01Rik, B130017i01rik, C76601, PARG1, Parg1, RGD1306185, RP11-255E17.1, sb:cb905, zgc:63950Protein level used designations for PARG1
- Rho GTPase activating protein 29
- rho GTPase-activating protein 29
- rho-type GTPase-activating protein 29
- PTPL1-associated RhoGAP 1
- rho GTPase-activating protein 29-like
- PTPL1-associated RhoGAP 1 (PARG1)
- PTPL1-associated RhoGAP protein 1
Avez-vous cherché autre chose?
Vous êtes ici:
